Aurora, CONCT07387367Now EnrollingIRB Ready

Adenovirus Infections Clinical Trial in Aurora, CO

Access cutting-edge adenovirus infections treatment through this clinical trial at a research site in Aurora. Study-provided care at no cost to qualified participants.

Sponsored by SymBio Pharmaceuticals

Quick Self-Assessment

See if you qualify for this Aurora location

Preparing your pre-screening questions…

Expert Care in Aurora

Access adenovirus infections specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related adenovirus infections treatment provided free

Apply for This Aurora Location

Check if you qualify for this adenovirus infections clinical trial in Aurora, CO

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Aurora

    Convenient for CO residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Aurora site if eligible
  4. 4Begin participation

About This Adenovirus Infections Study in Aurora

This randomized, open-label, parallel group, two-arm, multi-center assessment will compare IV BCV with IV CDV in adult and pediatric allogeneic HCT recipients with AdV viremia. A virologic response-driven approach to duration of treatment will be evaluated, in which randomized subjects are treated with either BCV or CDV until AdV viremia is confirmed as undetectable or until a maximum of 12 weeks of therapy, whichever occurs first. All subjects will be followed for a total of 24 weeks post-randomization, regardless of treatment assignment. Subjects will be assessed on a weekly basis through the end of treatment visit (EOT). Additional assessments will be performed at the test of cure (TOC) visit, which is 4 weeks after the last dose of study drug and at Weeks 12 and 24 post W1D1.

Sponsor: SymBio Pharmaceuticals

Who Can Participate

Inclusion Criteria

Male and female, post-allo HCT within last 180 days, aged 2 months and older at time of signing informed consent form.
Subject/Guardian willing and able to understand and provide written informed consent to participate in the study.
In the investigator's judgement, the subject's clinical condition justifies treatment with IV BCV or IV CDV for AdV infection.
Has adenoviremia, based on any of:
AdV viremia DNA ≥10,000 IU/mL, OR
Two consecutive and rising AdV viremia DNA results of ≥1,000 IU/mL at screening, OR
AdV viremia DNA of ≥1,000 IU/mL, AND 1\. Lymphocyte count \<180/mm3, OR 2. Received T cell depletion, cord blood, or haploidentical transplant, OR 3. prior alemtuzumab, OR 4. anti-thymocyte globulin (ATG)

Exclusion Criteria

Subject received an allo-HCT with a matched sibling donor
Subject received more than 5 mg/kg of CDV for any reason in the 21 days prior to first dose of study drug.
Subject is allergic or hypersensitive to IV BCV or IV CDV or any of their components.
Subject received anti-AdV-specific cell-based therapy within 3 weeks prior to W1D1 or an anti-AdV vaccine at any time.
Subject has participated in any other investigational study within 30 days (or within 5.5 half-lives of the investigational product, whichever is longer) before signing the informed consent form (ICF), is currently participating in another interventional treatment trial with an investigational agent or is using an investigational device at the time of Screening.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Aurora?

Yes, this clinical trial (NCT07387367) has an active research site in Aurora, CO that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Adenovirus Infections Treatment Options in Aurora, CO

If you're searching for adenovirus infections treatment options in Aurora, CO, this clinical trial (NCT07387367) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Aurora research site is actively enrolling participants for this clinical trial. You'll receive care from experienced adenovirus infections specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all adenovirus infections clinical trials near you to find additional studies recruiting in your area.

More Alzheimers Disease Trials in Aurora, CO

See all alzheimers disease clinical trials recruiting in Aurora — not just this study.

Browse Alzheimers Disease Trials in Aurora →

Browse More Trials by Condition

Alzheimers Disease TrialsAtopic Dermatitis TrialsAll Conditions →

Ready to Join in Aurora?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Aurora, CO